Eribulin Mesylate - NDC Database

13 records found
Page:1
0143-9167 Jun 28, 2024
Eribulin Mesylate .5 mg/ml Intravenous Injection by Hikma Pharmaceuticals USA Inc.
0781-3391 Jul 07, 2025
Eribulin Mesylate .5 mg/ml Intravenous Injection by Sandoz Inc
10019-080 Oct 01, 2024
Eribulin Mesylate .5 mg/ml Intravenous Injection by Baxter Healthcare Corporation
40033-364 Aug 05, 2025
Eribulin Mesylate .5 mg/ml Intravenous Injection by Kindos Pharmaceuticals Co., Ltd.
60505-6289 May 06, 2024
Eribulin Mesylate .5 mg/ml Intravenous Injection by Apotex Corp.
60505-6435 Mar 19, 2025
Eribulin Mesylate .5 mg/ml Intravenous Injection by Apotex Corp.
68001-656 Sep 15, 2025
Eribulin Mesylate .5 mg/ml Intravenous Solution by Bluepoint Laboratories
68083-592 Apr 05, 2024
Eribulin Mesylate .5 mg/ml Intravenous Injection by Gland Pharma Limited
68462-770 Aug 05, 2025
Eribulin Mesylate .5 mg/ml Intravenous Injection by Glenmark Pharmaceuticals Inc., USA
70095-080 May 15, 2025
Eribulin Mesylate .5 mg/ml Intravenous Injection by Sun Pharmaceutical Industries Limited
71731-4171 Mar 04, 2025
Eribulin Mesylate .5 mg/ml Intravenous Injection by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
72603-368 Dec 05, 2025
Eribulin Mesylate .5 mg/ml Intravenous Solution by Northstar Rx LLC
81298-3890 Jul 22, 2024
Eribulin Mesylate .5 mg/ml Intravenous Solution by Long Grove Pharmaceuticals, LLC
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.